Our Story

Be Informed. Be Smart. Be Sure.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean feugiat dictum lacus, ut hendrerit mi pulvinar vel. Fusce id nibh at neque eleifend tristique at sit amet libero. In aliquam in nisl nec sollicitudin. Sed consectetur volutpat sem vitae facilisis. Fusce tristique, magna ornare facilisis sagittis, tortor mi auctor libero, non pharetra sem ex eu felis. Aenean egestas ut purus nec vehicula. Morbi eu nisi erat. Nam mattis id lectus sit amet mattis. Suspendisse eget tristique neque

Working Hours

Monday - Friday 09:00AM-17:00PM
Saturday - Sunday CLOSED

Latest News

    No posts were found.


PhysIQ Wins DPharm IDOL 2017

PhysIQ Wins DPharm IDOL 2017

PhysIQ, a Chicago-based leader in developing solutions that leverage artificial intelligence (AI) to empower digital health for ambulatory patient monitoring and clinical trial support, was named DPharm Idol 2017 at the 7th annual DPharm: Disruptive Innovations to Advance Clinical Trials Conference.  Amid tough competition, PhysIQ’s VP Business Development had only six minutes to pitch the company’s contribution to disrupting the future of clinical trials.  The conference was held earlier this month in Boston Massachusetts.

Recently, the Global Health Sciences (GHS) Fund through Quark Venture and GF Securities announced a $2 million investment in PhysIQ.

“We are pleased to see PhysIQ’s game-changing product being recognized at the DPharm, a conference that focuses on innovations, new models and collaborations to advance clinical trials,” said Karimah Es Sabar.

Go here for more information about PhysIQ’s recognition.

Quark Venture
No Comments

Sorry, the comment form is closed at this time.